PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
Clinical trial NCT02571725 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02571725
- Sponsor
- New Mexico Cancer Research Alliance
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-23
- Primary completion
- 2020-12-02
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.